Hartford Business Journal

August 8, 2016

Issue link: https://nebusinessmedia.uberflip.com/i/711528

Contents of this Issue


Page 0 of 23

G R E AT E R H A R T F O R D ' S B U S I N E S S N E W S w w w. H a r t f o rd B u s i n e s s . c o m For more B2B news visit AUGUST 8, 2016 Volume 24, Number 36 $3.00 Subscribe online JOIN US! 'BLACK TIE & BLUE JEANS' ANNIVERSARY EVENT WEDNESDAY, SEPT. 14, 2016 CT CONVENTION CENTER | HARTFORD 20th ANNIVERSARY 19 9 7-2 0 1 6 Index ■ Week in Review: PG. 6 ■ Focus: PG. 8 ■ The List: PG. 10 ■ Deal Watch: PG. 16 ■ Corporate Profile: PG. 16 ■ Movers & Shakers: PG. 18 ■ Opinion & Commentary: PG. 20 Untaxed Burden A new Hartford Business Journal analysis has found that 59 percent of the real estate within the city of Hartford is untaxed because its owners are nonprofits or other tax-exempt entities. PG. 3 FOCUS: STARTUPS & ENTREPRENEURS Meeting of the Minds As Connecticut puts more focus on attracting and supporting startups, the state has begun to see the emergence of startup specific networking organizations. PG. 8 Low oil prices present early challenge to CT's $7B gas expansion By Matt Pilon mpilon@HartfordBusiness.com W hen Connecticut launched its ambitious $7 billion, 10-year effort in 2014 to convert approximately 280,000 utility customers to natural gas, the plan's success hinged on fed- eral government projections that oil prices would climb for the next decade or more. But that hasn't happened so far. In fact, oil prices nose- dived in 2014 and have remained at depressed levels, causing the state to fall behind its pro- jected natural gas conversion pace early on. Utilities say they're confident Building Bioscience A N H B J S E R I E S O N C T ' S B I O S C I E N C E S E C T O R Vaccine Voyage Dual CEO Almassian tees up CaroGen's next stage After decades in the biotech industry, Bijan Almassian is leading the charge to raise millions of dollars for Farmington vaccine maker CuroGen. P H O T O | S T E V E L A S C H E V E R H artford Business Journal's year-long series on Connecticut's bioscience industry continues this week with a look at Farmington-based CaroGen and its co-founder Bijan Almassian. The company is developing a therapeutic vaccine to treat various viruses including Hepatitis B and Zika. CaroGen is also on the cusp of raising poten- tially millions of dollars to advance its research to clinical trials. Find out more on PG. 12 Continued on page 14 A construction crew works on a natural gas pipeline expansion. P H O T O | C O N T R I B U T E D

Articles in this issue

Links on this page

Archives of this issue

view archives of Hartford Business Journal - August 8, 2016